Is ELUT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ELUT. It does not provide personalized investment advice.

ELUT (Elutia Inc. Class A Common Stock) Stock Analysis - Financials

Elutia Inc. Class A Common Stock (ELUT) is a publicly traded Healthcare sector company. As of July 16, 2026, ELUT trades at $0.86 with a market cap of $42.44M and a P/E ratio of 0.75. ELUT moved +3.14% today. Year to date, ELUT is +37.14%; over the trailing twelve months it is -53.20%. Its 52-week range spans $0.50 to $5.12. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces ELUT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are ELUT's key financials?

ELUT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ELUT recently traded at $0.86. Market cap is $42.44M. P/E ratio is 0.75. Revenue is $12.29M.

ELUT Key Metrics

Key financial metrics for ELUT
Metric	Value
Price	$0.86
Market Cap	$42.44M
P/E Ratio	0.75
EPS	$1.29
Dividend Yield	0.00%
52-Week High	$5.12
52-Week Low	$0.50
Volume	66.44K
Avg Volume	0
Revenue (TTM)	$12.29M
Net Income	$53.38M
Gross Margin	53.66%

ELUT Analyst Consensus

1 analysts cover ELUT: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.

Common questions about ELUT

What are ELUT's key financials?: ELUT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ELUT recently traded at $0.86. Market cap is $42.44M. P/E ratio is 0.75. Revenue is $12.29M.
Is ELUT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ELUT. It does not provide personalized investment advice.